Effect of Adding Electroacupuncture to Anti-cancer Therapy-induced Peripheral Neuropathy

Summary

This study is being done to evaluate the potential benefits of using electroacupuncture to reduce the severity of chemotherapy-induced peripheral neuropathy for patients with peripheral neuropathy after chemotherapy.

Eligibility

Inclusion Criteria:

* 18 years of age or older, of any nationality.
* Patients diagnosed with malignant tumor.
* Eligible patients will report altered sensations and/or pain and/or other neurological symptoms, with a grade between 2-3 for chemotherapy-induced peripheral neuropathy on the National Cancer Institute (NCI) Common Toxicity Criteria for Adverse Events-version 5.0 (NCI-CTCAE.v-5.0).
* Predicted life expectancy of ≥3 months.
* Intact skin without any breaches or purulent discharge.
* Written informed consent by the patient before enrolment Patients must be able to comply with the study protocol, which includes attending the treatment sessions on time and completing the study questionnaires in accordance with the study protocol.

Exclusion Criteria:

* History of pre-existing peripheral neuropathy before chemotherapy, including alcoholism, vitamin B deficiency, diabetes, HIV, congenital neuropathy, and toxic neuropathy.
* Patients with skin damage, pus or scar at the acupuncture stimulation area.
* Patients who are pregnant or breastfeeding.
* Significant mental conditions.
* Patients not fulfilling the inclusion criteria.
* Patients receiving other acupuncture treatments during the trial.

Conditions2

Browse More Trials